ロード中...
Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy
Survival of all non-small cell lung cancer (NSCLC) patients is disappointing, with a 5-year survival of 18%. Staging NSCLC patients is crucial because it determines the choice of treatment and prognosis. Clinical staging is a complex process that comes with many challenges and with low accuracy betw...
保存先:
| 出版年: | Ther Adv Med Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564882/ https://ncbi.nlm.nih.gov/pubmed/29081843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017722746 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|